Antibody Drug Conjugate News and Research

RSS
LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

Iksuda Therapeutics closes $47 million financing round

Iksuda Therapeutics closes $47 million financing round

Study provides new insight on how HER2-low tumors may evolve in breast cancer patients

Study provides new insight on how HER2-low tumors may evolve in breast cancer patients

UMass Amherst researchers achieve breakthrough in the fight against cancer

UMass Amherst researchers achieve breakthrough in the fight against cancer

Researchers develop an effective strategy to fight against chronic myelomonocytic leukemia

Researchers develop an effective strategy to fight against chronic myelomonocytic leukemia

New technology shows encouraging results for treating osteosarcoma

New technology shows encouraging results for treating osteosarcoma

Targeted therapy achieves excellent outcomes, reduces side effects in high-risk Hodgkin lymphoma

Targeted therapy achieves excellent outcomes, reduces side effects in high-risk Hodgkin lymphoma

Advancing the Diagnosis and Treatment of Ovarian Cancer

Advancing the Diagnosis and Treatment of Ovarian Cancer

Researchers confirm a threshold value for non-invasive imaging biomarker

Researchers confirm a threshold value for non-invasive imaging biomarker

Study: Targeted therapy prolongs survival in patients with advanced bladder cancer

Study: Targeted therapy prolongs survival in patients with advanced bladder cancer

Pediatric brain tumors can be classified using diffusion weighted imaging and machine learning

Pediatric brain tumors can be classified using diffusion weighted imaging and machine learning

New type of drug significantly increases survival of bladder cancer patients

New type of drug significantly increases survival of bladder cancer patients

ADC histogram analysis can predict tumor proliferation, survival in immunocompetent patients with PCNSL

ADC histogram analysis can predict tumor proliferation, survival in immunocompetent patients with PCNSL

Why is COVID-19 more severe among adults than children?

Why is COVID-19 more severe among adults than children?

Novel antibody-drug conjugate shows 29% response rate in rare blood cancer

Novel antibody-drug conjugate shows 29% response rate in rare blood cancer

Researchers evaluate safety of novel therapy for patients with non-Hodgkin lymphoma

Researchers evaluate safety of novel therapy for patients with non-Hodgkin lymphoma

CEAT project for improving ovarian cancer diagnosis, treatment shows promise

CEAT project for improving ovarian cancer diagnosis, treatment shows promise

Ovarian cancer project shows promise

Ovarian cancer project shows promise

Researchers develop novel chemo-immunotherapy agent to treat pancreatic tumors

Researchers develop novel chemo-immunotherapy agent to treat pancreatic tumors

Researchers identify a potential target for small cell lung cancer

Researchers identify a potential target for small cell lung cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.